| 1 |
Sugawara Y, Hirakawa Y, Nagasu H, Narita A, Katayama A, Wada J, Shimizu M, Wada T, Kitamura H, Nakano T, Yokoi H, Yanagita M, Goto S, Narita I, Koshiba S, Tamiya G, Nangaku M, Yamamoto M, Kashihara N. Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank. J Hum Genet 2023;68:55-64. [PMID: 36404353 DOI: 10.1038/s10038-022-01094-1] [Reference Citation Analysis]
|
| 2 |
Zhang Z, Li F, Li Y, Li Z, Jia G. In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells. Clin Breast Cancer 2022:S1526-8209(22)00291-9. [PMID: 36639265 DOI: 10.1016/j.clbc.2022.12.013] [Reference Citation Analysis]
|
| 3 |
Lin Y, Wu F, Zhuang Y, Chu L, Ding T, Qu Q, Li X, Cui Y, Hong C. PCMT1 has Potential Prognostic Value and Promotes Cell Growth and Motility in Breast Cancer.. [DOI: 10.21203/rs.3.rs-2349165/v1] [Reference Citation Analysis]
|
| 4 |
Zhang K, Wang J, Zhu Y, Liu X, Li J, Shi Z, Cao M, Li Y. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis. Front Oncol 2022;12:844990. [PMID: 35686089 DOI: 10.3389/fonc.2022.844990] [Reference Citation Analysis]
|
| 5 |
Belkourchia F, Desrosiers RR. The Protein L-Isoaspartyl (D-Aspartyl) Methyltransferase Regulates Glial-to-Mesenchymal Transition and Migration Induced by TGF-β1 in Human U-87 MG Glioma Cells. Int J Mol Sci 2022;23:5698. [PMID: 35628507 DOI: 10.3390/ijms23105698] [Reference Citation Analysis]
|
| 6 |
Guo J, Du X, Li C, Velasco-velázquez MA. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer. BioMed Research International 2022;2022:1-18. [DOI: 10.1155/2022/4434887] [Reference Citation Analysis]
|
| 7 |
Zhang J, Li Y, Liu H, Zhang J, Wang J, Xia J, Zhang Y, Yu X, Ma J, Huang M, Wang J, Wang L, Li Q, Cui R, Yang W, Xu Y, Feng W. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. J Exp Clin Cancer Res 2022;41:24. [PMID: 35033172 DOI: 10.1186/s13046-022-02242-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Boudier-Lemosquet A, Mahler A, Bobo C, Dufossée M, Priault M. Introducing protein deamidation: Landmark discoveries, societal outreach, and tentative priming workflow to address deamidation. Methods 2021:S1046-2023(21)00269-3. [PMID: 34843979 DOI: 10.1016/j.ymeth.2021.11.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Belkourchia F, Desrosiers RR. The enzyme L-isoaspartyl (D-aspartyl) methyltransferase promotes migration and invasion in human U-87 MG and U-251 MG glioblastoma cell lines. Biomed Pharmacother 2021;140:111766. [PMID: 34082401 DOI: 10.1016/j.biopha.2021.111766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Dong LM, Zhang XL, Mao MH, Li YP, Zhang XY, Xue DW, Liu YL. LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1. Front Cell Dev Biol 2021;9:650999. [PMID: 33898446 DOI: 10.3389/fcell.2021.650999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Zhang C, Hu J, Li H, Ma H, Othmane B, Ren W, Yi Z, Qiu D, Ou Z, Chen J, Zu X. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. Front Oncol 2021;11:648968. [PMID: 33869048 DOI: 10.3389/fonc.2021.648968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 12 |
Simko V, Belvoncikova P, Csaderova L, Labudova M, Grossmannova K, Zatovicova M, Kajanova I, Skultety L, Barathova M, Pastorek J. PIMT Binding to C-Terminal Ala459 of CAIX Is Involved in Inside-Out Signaling Necessary for Its Catalytic Activity. Int J Mol Sci 2020;21:E8545. [PMID: 33198416 DOI: 10.3390/ijms21228545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 13 |
Biterge-süt B, Bali DF. Lösemi patogenezinde miRNA 15a/16–1 lokus delesyonlarının ve Protein L-isoaspartate O-methyltransferase (PCMT1) enziminin rolü. SDÜ Tıp Fakültesi Dergisi 2019. [DOI: 10.17343/sdutfd.442996] [Reference Citation Analysis]
|
| 14 |
Ahluwalia P, Mondal AK, Bloomer C, Fulzele S, Jones K, Ananth S, Gahlay GK, Heneidi S, Rojiani AM, Kota V, Kolhe R. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Int J Mol Sci 2019;20:E3818. [PMID: 31387239 DOI: 10.3390/ijms20153818] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 15 |
Mishra PKK, Mahawar M. PIMT-Mediated Protein Repair: Mechanism and Implications. Biochemistry (Mosc) 2019;84:453-63. [PMID: 31234761 DOI: 10.1134/S0006297919050018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Dong L, Ding H, Li Y, Xue D, Li Z, Liu Y, Zhang T, Zhou J, Wang P. TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer. Int J Biol Macromol 2019;121:200-6. [PMID: 30267820 DOI: 10.1016/j.ijbiomac.2018.09.168] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Dong L, Ding H, Li Y, Xue D, Liu Y. LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer. Cancer Manag Res 2018;10:2799-807. [PMID: 30154672 DOI: 10.2147/CMAR.S170526] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
|
